AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 52 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,644,410 | -20.9% | 1,963,479 | 0.0% | 0.15% | -21.0% |
Q2 2023 | $33,673,665 | -15.0% | 1,963,479 | 0.0% | 0.20% | -9.3% |
Q1 2023 | $39,603,371 | -31.6% | 1,963,479 | -0.7% | 0.22% | -38.2% |
Q4 2022 | $57,922,232 | +76.5% | 1,976,868 | -0.1% | 0.35% | +61.9% |
Q3 2022 | $32,821,000 | +1.4% | 1,979,568 | -4.4% | 0.22% | +16.8% |
Q2 2022 | $32,354,000 | -14.7% | 2,070,010 | 0.0% | 0.18% | -15.6% |
Q1 2022 | $37,943,000 | +75.7% | 2,070,010 | +13.0% | 0.22% | +107.6% |
Q4 2021 | $21,597,000 | -37.7% | 1,831,789 | +10.9% | 0.10% | -30.9% |
Q3 2021 | $34,663,000 | +6.3% | 1,652,171 | +15.7% | 0.15% | +6.3% |
Q2 2021 | $32,614,000 | – | 1,428,571 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 603,762 | $8,193,050 | 18.42% |
TCG Crossover Management, LLC | 2,201,274 | $29,871,288 | 4.40% |
Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27,672,609 | 4.29% |
Sofinnova Investments, Inc. | 3,758,686 | $51,005,369 | 3.22% |
GREAT POINT PARTNERS LLC | 1,091,233 | $14,808,032 | 2.70% |
RA Capital Management | 8,263,982 | $112,142,236 | 2.21% |
Cormorant Asset Management, LP | 1,561,696 | $21,192,215 | 1.24% |
Frazier Life Sciences Management, L.P. | 1,204,867 | $16,350,045 | 1.09% |
Octagon Capital Advisors LP | 497,370 | $6,749,311 | 1.04% |
Ghost Tree Capital, LLC | 201,197 | $2,730,243 | 0.90% |